Robert De Vaere joins Horizon Therapeutics
This article was originally published in Scrip
Executive Summary
The private US biopharmaceutical company Horizon Therapeutics has named Robert De Vaere executive vice-president and chief financial officer. He most recently served as senior vice-president of finance and administration, and chief financial officer at IDM Pharma.